ClinicalTrials.Veeva

Menu

Smartshoes for Freezing of Gait in Parkinson's Disease

Stanford University logo

Stanford University

Status

Not yet enrolling

Conditions

Parkinson Disease

Treatments

Device: Smartshoes with haptic vibration feedback

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a pilot research study aimed at evaluating whether an FDA listed wearable shoe with capability to deliver vibration feedback can be safe and tolerable for patients with Parkinson disease and control participants and explore whether such a feedback can be useful for treating freezing of gait (FOG) in patients with Parkinson disease.

Enrollment

20 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

For patients with Parkinson disease:

  • diagnosis of PD according to the UK Brain Bank criteria
  • Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication
  • Self-report episodes of FoG based on item 1 of the NFOG-Q, and score of 3 on item 2, part II

For patients with Parkinson disease withOUT freezing of gait:

  • diagnosis of PD according to the UK Brain Bank criteria
  • Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication

For all participants (PD with or without freezing, or age-matched controls):

  • adult age 40-80
  • able to walk 10 minutes at baseline
  • able to provide consent
  • able to read and write in English at an 8th grade level.

Exclusion criteria

For all participants (PD with or without freezing, or age-matched controls)

  • moderate to severe peripheral neuropathy (based on self report or clinical exam using vibration tuning fork) which may limit ability to sense the vibratory feedback
  • use of orthotics incompatible with the haptic wearable shoes
  • severe balance deficits or daily falls at baseline
  • patients with dementia (MoCA<18) who are not able to appropriately provide consent for the study
  • pregnant persons

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

20 participants in 3 patient groups

Parkinson's disease with freezing episodes
Experimental group
Description:
Participants perform 3 walking tasks in random order: 1 with receiving vibrotactile feedback in swing-phase of gait, 1 with receiving vibrotactile feedback in metronome (regularly timed) vibration (set at low/medium/fast based on preferred/natural walking speed of the patient at baseline), and another with no vibration.
Treatment:
Device: Smartshoes with haptic vibration feedback
Parkinson's disease without freezing episodes
Experimental group
Description:
Participants perform 3 walking tasks in random order: 1 with receiving vibrotactile feedback in swing-phase of gait, 1 with receiving vibrotactile feedback in metronome (regularly timed) vibration (set at low/medium/fast based on preferred/natural walking speed of the patient at baseline), and another with no vibration.
Treatment:
Device: Smartshoes with haptic vibration feedback
Healthy Controls
Experimental group
Description:
Participants perform 3 walking tasks in random order: 1 with receiving vibrotactile feedback in swing-phase of gait, 1 with receiving vibrotactile feedback in metronome (regularly timed) vibration (set at low/medium/fast based on preferred/natural walking speed of the patient at baseline), and another with no vibration.
Treatment:
Device: Smartshoes with haptic vibration feedback

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems